Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

May 10, 2022

Study Completion Date

May 10, 2022

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

Ifenprodil

Ifenprodil 20 mg TID

Trial Locations (6)

Vale Medical Practice, Brookvale

Concord Repatriation General Hospital, Concord

Westmead Hospital, Westmead

Cairns Hospital, Cairns

The University of Otago, Christchurch

Waikato Hospital, Hamilton